Gut:NAD代谢途径与肠道炎症

2017-09-08 zhangfan MedSci原创

研究发现还原型烟酰胺腺嘌呤二核苷酸免疫代谢对于黏膜免疫十分重要,烟酰胺磷酸核糖基转移酶抑制剂具备急性肠道炎症的治疗前景

烟酰胺磷酸核糖基转移酶 (NAMPT, 也被称为前B细胞集落刺激因子或内脂素)在还原型烟酰胺腺嘌呤二核苷酸(NAD)维持以及NAD补救途径过程中发挥了重要作用。近日研究人员考察了炎症、代谢、转录途径与NAD代谢之间的关系。

研究人员首先考察了NAMPT抑制剂FK866与葡聚糖硫酸钠(DSS)诱导结肠炎模型以及溃疡性结肠炎相关癌症之间的关系,之后考察了NAD敲除对小鼠和人原代单核细胞/巨噬细胞的分化的影响,最后比较了FK866、地塞米松和英夫利昔单抗对IBD患者肠黏膜固有层单个核细胞(LPMNC)的作用。

研究发现FK866可以改善DSS诱导肠炎并抑制炎症相关的肿瘤发生。FK866可抑制NAMPT活性,减少粘膜中的NAD,减少PARP1, Sirt6 以及 CD38等NAD依赖酶的丰度和活性,降低核因子κb活化,减少炎性单核细胞、巨噬细胞和活化T细胞细胞浸润。特别是FK866可有效抑制IBD患者LPMNCs细胞因子释放。研究认为FK866的治疗机制与单核-巨噬细胞生物学和巨噬细胞极化改变相关,该过程与CD86, CD38, MHC-II和IL6减少以及CD206, Egr2和IL-10的增加相关。

研究发现还原型烟酰胺腺嘌呤二核苷酸免疫代谢对于黏膜免疫十分重要,烟酰胺磷酸核糖基转移酶抑制剂具备急性肠道炎症的治疗前景。

原始出处:

Romana R Gerner et al. NAD metabolism fuels human and mouse intestinal inflammation. Gut. Sept 6 2017.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1735833, encodeId=521d1e35833f0, content=<a href='/topic/show?id=035f2548968' target=_blank style='color:#2F92EE;'>#代谢途径#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25489, encryptionId=035f2548968, topicName=代谢途径)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cd34012654, createdName=mashirong, createdTime=Sun Aug 05 17:55:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242783, encodeId=8c4d242e8384, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Sep 11 07:37:49 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414760, encodeId=8d9b1414e605e, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598492, encodeId=9541159849259, content=<a href='/topic/show?id=829b124e643' target=_blank style='color:#2F92EE;'>#NAD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12476, encryptionId=829b124e643, topicName=NAD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0018615070, createdName=pandamao2016, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241974, encodeId=ac4e2419e4f2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 09 00:18:39 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241970, encodeId=7b952419e007, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Sep 09 00:14:51 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241794, encodeId=c472241e945b, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Sep 08 14:27:23 CST 2017, time=2017-09-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1735833, encodeId=521d1e35833f0, content=<a href='/topic/show?id=035f2548968' target=_blank style='color:#2F92EE;'>#代谢途径#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25489, encryptionId=035f2548968, topicName=代谢途径)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cd34012654, createdName=mashirong, createdTime=Sun Aug 05 17:55:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242783, encodeId=8c4d242e8384, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Sep 11 07:37:49 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414760, encodeId=8d9b1414e605e, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598492, encodeId=9541159849259, content=<a href='/topic/show?id=829b124e643' target=_blank style='color:#2F92EE;'>#NAD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12476, encryptionId=829b124e643, topicName=NAD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0018615070, createdName=pandamao2016, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241974, encodeId=ac4e2419e4f2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 09 00:18:39 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241970, encodeId=7b952419e007, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Sep 09 00:14:51 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241794, encodeId=c472241e945b, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Sep 08 14:27:23 CST 2017, time=2017-09-08, status=1, ipAttribution=)]
    2017-09-11 flysky120

    学习一下知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1735833, encodeId=521d1e35833f0, content=<a href='/topic/show?id=035f2548968' target=_blank style='color:#2F92EE;'>#代谢途径#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25489, encryptionId=035f2548968, topicName=代谢途径)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cd34012654, createdName=mashirong, createdTime=Sun Aug 05 17:55:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242783, encodeId=8c4d242e8384, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Sep 11 07:37:49 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414760, encodeId=8d9b1414e605e, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598492, encodeId=9541159849259, content=<a href='/topic/show?id=829b124e643' target=_blank style='color:#2F92EE;'>#NAD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12476, encryptionId=829b124e643, topicName=NAD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0018615070, createdName=pandamao2016, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241974, encodeId=ac4e2419e4f2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 09 00:18:39 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241970, encodeId=7b952419e007, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Sep 09 00:14:51 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241794, encodeId=c472241e945b, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Sep 08 14:27:23 CST 2017, time=2017-09-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1735833, encodeId=521d1e35833f0, content=<a href='/topic/show?id=035f2548968' target=_blank style='color:#2F92EE;'>#代谢途径#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25489, encryptionId=035f2548968, topicName=代谢途径)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cd34012654, createdName=mashirong, createdTime=Sun Aug 05 17:55:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242783, encodeId=8c4d242e8384, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Sep 11 07:37:49 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414760, encodeId=8d9b1414e605e, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598492, encodeId=9541159849259, content=<a href='/topic/show?id=829b124e643' target=_blank style='color:#2F92EE;'>#NAD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12476, encryptionId=829b124e643, topicName=NAD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0018615070, createdName=pandamao2016, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241974, encodeId=ac4e2419e4f2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 09 00:18:39 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241970, encodeId=7b952419e007, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Sep 09 00:14:51 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241794, encodeId=c472241e945b, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Sep 08 14:27:23 CST 2017, time=2017-09-08, status=1, ipAttribution=)]
    2017-09-10 pandamao2016
  5. [GetPortalCommentsPageByObjectIdResponse(id=1735833, encodeId=521d1e35833f0, content=<a href='/topic/show?id=035f2548968' target=_blank style='color:#2F92EE;'>#代谢途径#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25489, encryptionId=035f2548968, topicName=代谢途径)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cd34012654, createdName=mashirong, createdTime=Sun Aug 05 17:55:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242783, encodeId=8c4d242e8384, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Sep 11 07:37:49 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414760, encodeId=8d9b1414e605e, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598492, encodeId=9541159849259, content=<a href='/topic/show?id=829b124e643' target=_blank style='color:#2F92EE;'>#NAD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12476, encryptionId=829b124e643, topicName=NAD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0018615070, createdName=pandamao2016, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241974, encodeId=ac4e2419e4f2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 09 00:18:39 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241970, encodeId=7b952419e007, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Sep 09 00:14:51 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241794, encodeId=c472241e945b, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Sep 08 14:27:23 CST 2017, time=2017-09-08, status=1, ipAttribution=)]
    2017-09-09 yfjms

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1735833, encodeId=521d1e35833f0, content=<a href='/topic/show?id=035f2548968' target=_blank style='color:#2F92EE;'>#代谢途径#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25489, encryptionId=035f2548968, topicName=代谢途径)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cd34012654, createdName=mashirong, createdTime=Sun Aug 05 17:55:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242783, encodeId=8c4d242e8384, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Sep 11 07:37:49 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414760, encodeId=8d9b1414e605e, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598492, encodeId=9541159849259, content=<a href='/topic/show?id=829b124e643' target=_blank style='color:#2F92EE;'>#NAD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12476, encryptionId=829b124e643, topicName=NAD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0018615070, createdName=pandamao2016, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241974, encodeId=ac4e2419e4f2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 09 00:18:39 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241970, encodeId=7b952419e007, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Sep 09 00:14:51 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241794, encodeId=c472241e945b, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Sep 08 14:27:23 CST 2017, time=2017-09-08, status=1, ipAttribution=)]
    2017-09-09 thlabcde

    好东西学习了!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1735833, encodeId=521d1e35833f0, content=<a href='/topic/show?id=035f2548968' target=_blank style='color:#2F92EE;'>#代谢途径#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25489, encryptionId=035f2548968, topicName=代谢途径)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cd34012654, createdName=mashirong, createdTime=Sun Aug 05 17:55:00 CST 2018, time=2018-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=242783, encodeId=8c4d242e8384, content=学习一下知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160718/IMG578C993D395567540.jpg, createdBy=59b81918946, createdName=flysky120, createdTime=Mon Sep 11 07:37:49 CST 2017, time=2017-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1414760, encodeId=8d9b1414e605e, content=<a href='/topic/show?id=af1a8169e60' target=_blank style='color:#2F92EE;'>#肠道炎症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81697, encryptionId=af1a8169e60, topicName=肠道炎症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f1f3086480, createdName=lancelotzzl, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598492, encodeId=9541159849259, content=<a href='/topic/show?id=829b124e643' target=_blank style='color:#2F92EE;'>#NAD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12476, encryptionId=829b124e643, topicName=NAD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b0018615070, createdName=pandamao2016, createdTime=Sun Sep 10 04:55:00 CST 2017, time=2017-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241974, encodeId=ac4e2419e4f2, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sat Sep 09 00:18:39 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241970, encodeId=7b952419e007, content=好东西学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92191944782, createdName=thlabcde, createdTime=Sat Sep 09 00:14:51 CST 2017, time=2017-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=241794, encodeId=c472241e945b, content=很好的文章.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Sep 08 14:27:23 CST 2017, time=2017-09-08, status=1, ipAttribution=)]
    2017-09-08 清风拂面

    很好的文章.谢谢分享

    0

相关资讯

粪菌移植如何治肠炎?

《西游记》中有这样一话,不知大家是否印象深刻?唐僧师徒来到朱紫国时,朱紫国王久病难以治愈,不能上朝治理政事,只好贴出皇榜,来招纳北往东来、中华外国的天下贤士,为自己治病。而悟空却让八戒刮了半盏锅底灰,又接了少半盏马尿,搅和一处,搓了三个核桃大的药丸,将国王的病治好了。这虽是吴承恩戏里天马行空的想法,但艺术来源于生活,祖国医学的诸多医案、医话中不乏类似的案例,病例记载中疗效也是很明显。《西游记》中,

Gut:活动性炎症性肠炎增加患者动脉血管事件发生率

炎症性肠炎患者其急性动脉血管事件发生率上升,特别是中年人群,活动性疾病独立增加患者血管风险

Aliment Pharmacol Ther:维多珠单抗治疗炎症性肠病是否安全

维多珠单抗可以明确识别α4β7整联蛋白,并选择性阻断肠道淋巴细胞运输:潜在提供肠道特异性免疫抑制。2017年7月,发表在《Aliment Pharmacol Ther》的一项系统评价调查了维多珠单抗治疗炎症性肠病的安全性。

Aliment Pharm Ther:接受联合疗法的炎性肠炎患者:硫唑嘌呤减量有效吗?

2017年7月,发表在《Aliment Pharmacol Ther》的一项由法国和美国科学家进行的开放标签、前瞻性、随机临床试验考察了联合治疗的炎性肠病(IBD)患者中,硫唑嘌呤(AZA)剂量减少的效果。

Cell:范祖森组Cell报道新型固有淋巴细胞在肠炎调控中的重要作用

在这项研究中,研究人员在肠道中鉴定出了一类新的称之为ILCregs(regulatory subpopulation of ILCs)的新型固有淋巴细胞,不同于传统的ILCs和调节性T细胞(Tregs),ILCregs具有独特基因表达特征

Am J Gastroenterol:肠炎患者肠道肿瘤风险因素研究

研究认为,免疫抑制及抗TNF药物不会增加炎症性肠病患者肠道肿瘤风险,高龄及吸烟是该类患者肿瘤高风险因素